MICRONISED PROGESTERONE

MICRONISED PROGESTERONE: Micronised progesterone is a prescription medication primarily used in hormone replacement therapy (HRT) and in the treatment of women with amenorrhea (absence of menstrual periods). It is a synthetic hormone that is similar to the naturally occurring hormone progesterone.

The mechanism of action of micronised progesterone involves binding to specific progesterone receptors in the body. This helps regulate the menstrual cycle and prepares the lining of the uterus for implantation of a fertilized egg. In HRT, it is used to supplement estrogen therapy, reducing the risk of endometrial hyperplasia (overgrowth of the uterine lining) caused by estrogen alone.

The recommended dose of micronised progesterone varies depending on the condition being treated. In general, for amenorrhea, a typical starting dose is 200 mg taken orally once daily for a specific duration, as determined by the healthcare provider. For HRT, the dose and duration may vary based on individual needs and treatment goals.

Common side effects of micronised progesterone may include drowsiness, dizziness, headache, breast tenderness, mood changes, abdominal bloating, and breakthrough bleeding or spotting. These side effects are usually mild and temporary. However, if any severe or persistent side effects occur, it is important to seek medical attention.

Some women may also experience allergic reactions to micronised progesterone. Signs of an allergic reaction may include rash, itching, swelling, severe dizziness, or difficulty breathing. If any of these symptoms occur, immediate medical attention should be sought.

As with any medication, it is important to follow the prescribed dosage and usage instructions provided by the healthcare provider. It is also important to inform the healthcare provider about any other medications or medical conditions before starting micronised progesterone, as certain drug interactions or contraindications may exist.